Marcus Foston and his co-investigator, Ulugbek Kamilov, both faculty members at the McKelvey School of Engineering, received a $577,780 grant from the U.S. Department of Energy to study ways to “upcycle” plastic waste.
Rachel Penczykowski, an assistant professor of biology in Arts & Sciences, won a prestigious National Science Foundation grant for early-career faculty who excel at mentorship and research. The award will fund a project investigating infestations of a common plant pathogen in the St. Louis area.
John Hendrix, a professor and founding chair of the Sam Fox School of Design & Visual Arts’ MFA in Illustration & Visual Culture program, was installed Jan. 26 as the Kenneth E. Hudson Professor of Art.
U.S. workers are cutting back on hours and that’s having a dramatic impact on domestic labor, according to new research from WashU economist Yongseok Shin.
New research from Calvin Lai, in Arts & Sciences, suggests that the daylong implicit bias-oriented training programs now common in most U.S. police departments are unlikely to reduce racial inequity in policing.
Amy Walter, a leader in information technology at Washington University for the past eight years, has been named associate vice chancellor and deputy chief information officer for research, clinical and medical education technologies across the university. She began in her new role Feb. 1.
Marcus Foston, an associate professor at the McKelvey School of Engineering, is one of 20 awardees selected by the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy facility, for this year’s exploratory call.
Tess Thompson, research assistant professor at the Brown School at Washington University in St. Louis, has received a five-year grant from the National Cancer Institute of the National Institutes of Health (NIH) to study unmet social needs of cancer patients and their caregivers, with the ultimate aim of improving outcomes for both.
Jonathan D. Cooper, a professor at the School of Medicine, received two grants totaling nearly $2.6 million over five years from the National Institutes of Health (NIH) to study gene therapy as a possible treatment for CLN1, a rare genetic disease that is fatal in children.